Cargando…
Transcatheter Aortic Valve Implantation and Cardiac Conduction Abnormalities: Prevalence, Risk Factors and Management
Over the last decades, transcatheter aortic valve implantation (TAVI) or replacement (TAVR) has become a potential, widely accepted, and effective method of treating aortic stenosis in patients at moderate and high surgical risk and those disqualified from surgery. The method evolved what translates...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531796/ https://www.ncbi.nlm.nih.gov/pubmed/37762995 http://dx.doi.org/10.3390/jcm12186056 |
_version_ | 1785111804163129344 |
---|---|
author | Szotek, Michał Drużbicki, Łukasz Sabatowski, Karol Amoroso, Gisella R. De Schouwer, Koen Matusik, Paweł T. |
author_facet | Szotek, Michał Drużbicki, Łukasz Sabatowski, Karol Amoroso, Gisella R. De Schouwer, Koen Matusik, Paweł T. |
author_sort | Szotek, Michał |
collection | PubMed |
description | Over the last decades, transcatheter aortic valve implantation (TAVI) or replacement (TAVR) has become a potential, widely accepted, and effective method of treating aortic stenosis in patients at moderate and high surgical risk and those disqualified from surgery. The method evolved what translates into a noticeable decrease in the incidence of complications and more beneficial clinical outcomes. However, the incidence of conduction abnormalities related to TAVI, including left bundle branch block and complete or second-degree atrioventricular block (AVB), remains high. The occurrence of AVB requiring permanent pacemaker implantation is associated with a worse prognosis in this group of patients. The identification of risk factors for conduction disturbances requiring pacemaker placement and the assessment of their relation to pacing dependence may help to develop methods of optimal care, including preventive measures, for patients undergoing TAVI. This approach is crucial given the emerging evidence of no worse outcomes for intermediate and low-risk patients undergoing TAVI in comparison to surgical aortic valve replacement. This paper comprehensively discusses the mechanisms, risk factors, and consequences of conduction abnormalities and arrhythmias, including AVB, atrial fibrillation, and ventricular arrhythmias associated with aortic stenosis and TAVI, as well as provides insights into optimized patient care, along with the potential of conduction system pacing and cardiac resynchronization therapy, to minimize the risk of unfavorable clinical outcomes. |
format | Online Article Text |
id | pubmed-10531796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105317962023-09-28 Transcatheter Aortic Valve Implantation and Cardiac Conduction Abnormalities: Prevalence, Risk Factors and Management Szotek, Michał Drużbicki, Łukasz Sabatowski, Karol Amoroso, Gisella R. De Schouwer, Koen Matusik, Paweł T. J Clin Med Review Over the last decades, transcatheter aortic valve implantation (TAVI) or replacement (TAVR) has become a potential, widely accepted, and effective method of treating aortic stenosis in patients at moderate and high surgical risk and those disqualified from surgery. The method evolved what translates into a noticeable decrease in the incidence of complications and more beneficial clinical outcomes. However, the incidence of conduction abnormalities related to TAVI, including left bundle branch block and complete or second-degree atrioventricular block (AVB), remains high. The occurrence of AVB requiring permanent pacemaker implantation is associated with a worse prognosis in this group of patients. The identification of risk factors for conduction disturbances requiring pacemaker placement and the assessment of their relation to pacing dependence may help to develop methods of optimal care, including preventive measures, for patients undergoing TAVI. This approach is crucial given the emerging evidence of no worse outcomes for intermediate and low-risk patients undergoing TAVI in comparison to surgical aortic valve replacement. This paper comprehensively discusses the mechanisms, risk factors, and consequences of conduction abnormalities and arrhythmias, including AVB, atrial fibrillation, and ventricular arrhythmias associated with aortic stenosis and TAVI, as well as provides insights into optimized patient care, along with the potential of conduction system pacing and cardiac resynchronization therapy, to minimize the risk of unfavorable clinical outcomes. MDPI 2023-09-19 /pmc/articles/PMC10531796/ /pubmed/37762995 http://dx.doi.org/10.3390/jcm12186056 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Szotek, Michał Drużbicki, Łukasz Sabatowski, Karol Amoroso, Gisella R. De Schouwer, Koen Matusik, Paweł T. Transcatheter Aortic Valve Implantation and Cardiac Conduction Abnormalities: Prevalence, Risk Factors and Management |
title | Transcatheter Aortic Valve Implantation and Cardiac Conduction Abnormalities: Prevalence, Risk Factors and Management |
title_full | Transcatheter Aortic Valve Implantation and Cardiac Conduction Abnormalities: Prevalence, Risk Factors and Management |
title_fullStr | Transcatheter Aortic Valve Implantation and Cardiac Conduction Abnormalities: Prevalence, Risk Factors and Management |
title_full_unstemmed | Transcatheter Aortic Valve Implantation and Cardiac Conduction Abnormalities: Prevalence, Risk Factors and Management |
title_short | Transcatheter Aortic Valve Implantation and Cardiac Conduction Abnormalities: Prevalence, Risk Factors and Management |
title_sort | transcatheter aortic valve implantation and cardiac conduction abnormalities: prevalence, risk factors and management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531796/ https://www.ncbi.nlm.nih.gov/pubmed/37762995 http://dx.doi.org/10.3390/jcm12186056 |
work_keys_str_mv | AT szotekmichał transcatheteraorticvalveimplantationandcardiacconductionabnormalitiesprevalenceriskfactorsandmanagement AT druzbickiłukasz transcatheteraorticvalveimplantationandcardiacconductionabnormalitiesprevalenceriskfactorsandmanagement AT sabatowskikarol transcatheteraorticvalveimplantationandcardiacconductionabnormalitiesprevalenceriskfactorsandmanagement AT amorosogisellar transcatheteraorticvalveimplantationandcardiacconductionabnormalitiesprevalenceriskfactorsandmanagement AT deschouwerkoen transcatheteraorticvalveimplantationandcardiacconductionabnormalitiesprevalenceriskfactorsandmanagement AT matusikpawełt transcatheteraorticvalveimplantationandcardiacconductionabnormalitiesprevalenceriskfactorsandmanagement |